$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
Pfizer: 100 days to produce variant vaccine
01:27pm, Friday, 26'th Nov 2021 Forexlive
1/3 of a year Ok, so that is a rough timescale in case this blows up. Also remember that BioNTech expects dat from lab tests on new South African COVID variant in two weeks and that may require a vaccine adjustment.
BioNTech expects more data on new COVID-19 variant in two weeks
01:19pm, Friday, 26'th Nov 2021 Seeking AlphaBioNTech testing vaccine effect against new variant
01:15pm, Friday, 26'th Nov 2021 Breaking the News 24/7
BioNTech SE said on Friday that it is testing the effectiveness of its Comirnaty vaccine, co-developed with Pfizer Inc, against the new southern African variant of COVID-19. BioNTech stated that it e…
Black Friday Turns Red On "Terrible News" - Global Markets Crater On "Nu Variant" Panic
01:12pm, Friday, 26'th Nov 2021 Zero Hedge
Black Friday Turns Red On "Terrible News" - Global Markets Crater On "Nu Variant" Panic The Friday after thanksgiving is called black Friday because that''s when retailers finally turn profitable for the year. Not so much for market, however, because this morning it''s red as far as the eye can see. The culprit: the same one we discussed late last night - the emergence of a new coronavirus strain detected in South Africa, known as B.1.1.529, which reportedly carries an "extremely high number" of mutations and is “clearly very different” from previous incarnations, which may drive further waves of disease by evading the body’s defenses according to South African scientists, and soon, Anthony Fauci. British authorities think it is the most significant variant to date and have hurried to impose travel restrictions on southern Africa, as did Japan, the Czech Republic and Italy on Friday. The European Union also said it aimed to halt air travel from the region. "Markets have been quite complacent about the pandemic for a while, partly because economies have been able to withstand the impact of selective lockdown measures.
Dr. Gottlieb: The vaccines might be sufficient to control spread of new Covid variant
01:02pm, Friday, 26'th Nov 2021
Dr. Scott Gottlieb, former FDA commissioner, joins 'Closing Bell' to discuss the new Covid-19 variant. He says if the majority of the population is vaccinated it can be effective in protecting people
Pfizer-BioNTech investigating new Covid variant, while J&J say they are testing their vaccine against it
12:19pm, Friday, 26'th Nov 2021
Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest.
Wall Street Tumbles on Resurgence of Coronavirus
12:14pm, Friday, 26'th Nov 2021
Wall Street Tumbles on Resurgence of Coronavirus.
Forget reopening. The new COVID variant has 'stay-at-home' stocks rebounding.
12:12pm, Friday, 26'th Nov 2021
Little is known about the new COVID strain emerging in Africa. That hasn't stopped traders from betting big on lockdowns and a return to telework.
Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns
09:28am, Friday, 26'th Nov 2021
The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks like Zoom Video and Peloton.
The B.1.1.529 variant has been detected in South Africa, Botswana, Hong Kong, and Israel, and is spreading rapidly.
Pfizer/BioNTech's COVID Jab Gets CHMP Nod for Kids Aged 5-11
08:27am, Friday, 26'th Nov 2021
Pfizer (PFE)/BioNTech (BNTX) COVID-19 vaccine, Comirnaty, if approved for use in children aged five to 11, will be the first vaccine to be approved for administration in this age group in Europe
BioNTech (BNTX): Why The Price Jumped Today
08:15am, Friday, 26'th Nov 2021
The stock price of BioNTech SE (NASDAQ: BNTX) increased by over 7% pre-market today. This is why it happened.
Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years
06:28am, Friday, 26'th Nov 2021
The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc (NYSE: PFE) - BioNTech SE's (NASDAQ: BNTX)'s COVID-19 vaccine, Comirnaty, for children between
Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application, CHMP, 15/12/2020
02:32pm, Thursday, 25'th Nov 2021 EU Medicines Agency
EMAs human medicines committee (CHMP) and its experts have been working intensively over the past weeks to evaluate data submitted by BioNTech and
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 , , 01/12/2020
02:31pm, Thursday, 25'th Nov 2021 EU Medicines Agency
EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID19 mRNA vaccine developed by BioNTech and Pfizer. The
Sign In
Buy BNTX